Cargando…
Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom
Soft tissue sarcomas are a rare type of cancer generally treated with palliative chemotherapy when in the advanced stage. There is a lack of published health utility data for locally advanced “inoperable”/metastatic disease (ASTS), essential for calculating the cost-effectiveness of current and futu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613051/ https://www.ncbi.nlm.nih.gov/pubmed/23576896 http://dx.doi.org/10.1155/2013/863056 |
_version_ | 1782264703057133568 |
---|---|
author | Guest, Julian F. Sladkevicius, Erikas Gough, Nicholas Linch, Mark Grimer, Robert |
author_facet | Guest, Julian F. Sladkevicius, Erikas Gough, Nicholas Linch, Mark Grimer, Robert |
author_sort | Guest, Julian F. |
collection | PubMed |
description | Soft tissue sarcomas are a rare type of cancer generally treated with palliative chemotherapy when in the advanced stage. There is a lack of published health utility data for locally advanced “inoperable”/metastatic disease (ASTS), essential for calculating the cost-effectiveness of current and future treatments. This study estimated time trade-off (TTO) and standard gamble (SG) preference values associated with four ASTS health states (progressive disease, stable disease, partial response, complete response) among members of the general public in the UK (n = 207). The four health states were associated with decreases in preference values from full health. Complete response was the most preferred health state (mean utility of 0.60 using TTO). The second most preferred health state was partial response followed by stable disease (mean utilities were 0.51 and 0.43, respectively, using TTO). The least preferred health state was progressive disease (mean utility of 0.30 using TTO). The utility value for each state was significantly different from one another (P < 0.001). This study demonstrated and quantified the impact that different treatment responses may have on the health-related quality of life of patients with ASTS. |
format | Online Article Text |
id | pubmed-3613051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36130512013-04-10 Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom Guest, Julian F. Sladkevicius, Erikas Gough, Nicholas Linch, Mark Grimer, Robert Sarcoma Research Article Soft tissue sarcomas are a rare type of cancer generally treated with palliative chemotherapy when in the advanced stage. There is a lack of published health utility data for locally advanced “inoperable”/metastatic disease (ASTS), essential for calculating the cost-effectiveness of current and future treatments. This study estimated time trade-off (TTO) and standard gamble (SG) preference values associated with four ASTS health states (progressive disease, stable disease, partial response, complete response) among members of the general public in the UK (n = 207). The four health states were associated with decreases in preference values from full health. Complete response was the most preferred health state (mean utility of 0.60 using TTO). The second most preferred health state was partial response followed by stable disease (mean utilities were 0.51 and 0.43, respectively, using TTO). The least preferred health state was progressive disease (mean utility of 0.30 using TTO). The utility value for each state was significantly different from one another (P < 0.001). This study demonstrated and quantified the impact that different treatment responses may have on the health-related quality of life of patients with ASTS. Hindawi Publishing Corporation 2013 2013-03-17 /pmc/articles/PMC3613051/ /pubmed/23576896 http://dx.doi.org/10.1155/2013/863056 Text en Copyright © 2013 Julian F. Guest et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Guest, Julian F. Sladkevicius, Erikas Gough, Nicholas Linch, Mark Grimer, Robert Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom |
title | Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom |
title_full | Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom |
title_fullStr | Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom |
title_full_unstemmed | Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom |
title_short | Utility Values for Advanced Soft Tissue Sarcoma Health States from the General Public in the United Kingdom |
title_sort | utility values for advanced soft tissue sarcoma health states from the general public in the united kingdom |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613051/ https://www.ncbi.nlm.nih.gov/pubmed/23576896 http://dx.doi.org/10.1155/2013/863056 |
work_keys_str_mv | AT guestjulianf utilityvaluesforadvancedsofttissuesarcomahealthstatesfromthegeneralpublicintheunitedkingdom AT sladkeviciuserikas utilityvaluesforadvancedsofttissuesarcomahealthstatesfromthegeneralpublicintheunitedkingdom AT goughnicholas utilityvaluesforadvancedsofttissuesarcomahealthstatesfromthegeneralpublicintheunitedkingdom AT linchmark utilityvaluesforadvancedsofttissuesarcomahealthstatesfromthegeneralpublicintheunitedkingdom AT grimerrobert utilityvaluesforadvancedsofttissuesarcomahealthstatesfromthegeneralpublicintheunitedkingdom |